The CYP2C19*17 Variant is not Independently Associated with Clopidogrel Response

BACKGROUND: Cytochrome P450 2C19 (CYP2C19) is the principle enzyme responsible for converting clopidogrel into its active metabolite and genetic variants have been identified, most notably CYP2C19*2 and CYP2C19*17, that are believed to alter its activity/expression. OBJECTIVE: We evaluated whether t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lewis, JP, Stephens, SH, Horenstein, RB, O'Connell, JR, Ryan, K, Peer, CJ, Figg, WD., Spencer, SD, Pacanowski, MA, Mitchell, BD, Shuldiner, AR
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3773276/
https://ncbi.nlm.nih.gov/pubmed/23809542
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.12342
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak